Difei Wang1. 1. Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. wangdi@mail.nih.gov
Abstract
The catalytic activity of the histone deacetylase (HDAC) enzymes is directly relevant to the pathogenesis of cancer as well as several other diseases. HDAC inhibitors have been shown to have the potential to treat several types of cancers. The role of computational study of the HDAC enzymes is reviewed, with particular emphasis on the important role of molecular modeling to the development of HDAC inhibitors with improved efficacy and selectivity. The use of two computational approaches--one structure-based, and the second ligand-based--toward inhibitors against the different HDAC sub-classes, are summarized.
The catalytic activity of the histone deacetylase (n class="Gene">HDAC) enzymes is directly relevant to the pathogenesis of cancer as well as several other diseases. HDAC inhibitors have been shown to have the potential to treat several types of cancers. The role of computational study of the HDAC enzymes is reviewed, with particular emphasis on the important role of molecular modeling to the development of HDAC inhibitors with improved efficacy and selectivity. The use of two computational approaches--one structure-based, and the second ligand-based--toward inhibitors against the different HDAC sub-classes, are summarized.
Authors: John R Somoza; Robert J Skene; Bradley A Katz; Clifford Mol; Joseph D Ho; Andy J Jennings; Christine Luong; Andrew Arvai; Joseph J Buggy; Ellen Chi; Jie Tang; Bi-Ching Sang; Erik Verner; Robert Wynands; Ellen M Leahy; Douglas R Dougan; Gyorgy Snell; Marc Navre; Mark W Knuth; Ronald V Swanson; Duncan E McRee; Leslie W Tari Journal: Structure Date: 2004-07 Impact factor: 5.006
Authors: Alessandro Vannini; Cinzia Volpari; Gessica Filocamo; Elena Caroli Casavola; Mirko Brunetti; Debora Renzoni; Prasun Chakravarty; Chantal Paolini; Raffaele De Francesco; Paola Gallinari; Christian Steinkühler; Stefania Di Marco Journal: Proc Natl Acad Sci U S A Date: 2004-10-11 Impact factor: 11.205
Authors: Kalipso Halkidou; Luke Gaughan; Susan Cook; Hing Y Leung; David E Neal; Craig N Robson Journal: Prostate Date: 2004-05-01 Impact factor: 4.104
Authors: Qi Shi; Thomas M Kaiser; Zackery W Dentmon; Mariangela Ceruso; Daniela Vullo; Claudiu T Supuran; James P Snyder Journal: ACS Med Chem Lett Date: 2015-04-03 Impact factor: 4.345
Authors: Paris R Watson; Timothy W Craven; Xinting Li; Stephen Rettie; Parisa Hosseinzadeh; Fátima Pardo-Avila; Asim K Bera; Vikram Khipple Mulligan; Peilong Lu; Alexander S Ford; Brian D Weitzner; Lance J Stewart; Adam P Moyer; Maddalena Di Piazza; Joshua G Whalen; Per Jr Greisen; David W Christianson; David Baker Journal: Nat Commun Date: 2021-06-07 Impact factor: 14.919
Authors: Yudibeth Sixto-López; Emilie Marhuenda; Juan Benjamin García-Vazquez; Manuel Jonathan Fragoso-Vazquez; Martha Cecilia Rosales-Hernández; Oscar Zacarías-Lara; David Méndez-Luna; José Antonio Gómez-Vidal; David Cornu; Bakalara Norbert; José Correa-Basurto Journal: Cell Mol Neurobiol Date: 2021-03-19 Impact factor: 5.046
Authors: Katrien Van Beneden; Inge Mannaerts; Marina Pauwels; Christiane Van den Branden; Leo A van Grunsven Journal: Fibrogenesis Tissue Repair Date: 2013-01-02
Authors: Martin G Strebl; Arthur J Campbell; Wen-Ning Zhao; Frederick A Schroeder; Misha M Riley; Peter S Chindavong; Thomas M Morin; Stephen J Haggarty; Florence F Wagner; Tobias Ritter; Jacob M Hooker Journal: ACS Cent Sci Date: 2017-09-06 Impact factor: 14.553